TSW
ORGO icon

Thompson Siegel & Walmsley’s Organogenesis Holdings ORGO Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-429,182
Closed -$1.22M – 374
2024
Q1 		$1.22M Buy
429,182
+11,152
+3% +$37.9K 0.02% 266
2023
Q4 		$1.71M Sell
418,030
-39,370
-9% -$110K 0.03% 250
2023
Q3 		$1.46M Buy
457,400
+338,448
+285% +$1.08M 0.02% 254
2023
Q2 		$395K Buy
+118,952
New +$352K 0.01% 316

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thompson Siegel & Walmsley's ORGO Position: Q2 2024 in Review

Thompson Siegel & Walmsley sold out of Organogenesis Holdings (ORGO) in Q2 2024, closing a stake of 429,182 shares — an estimated $1.22M sold.

Thompson Siegel & Walmsley first reported a position in ORGO in Q2 2023 and held it in 4 quarters. The position peaked at $1.71M in Q4 2023. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2024.

  • Thompson Siegel & Walmsley reported no remaining Organogenesis Holdings position as of Q2 2024 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 429,182 Organogenesis Holdings shares in Q2 2024, an estimated $1.22M.
  • Thompson Siegel & Walmsley first reported a position in Organogenesis Holdings in Q2 2023 and held it in 4 quarters.
  • Thompson Siegel & Walmsley's Organogenesis Holdings position peaked at $1.71M in Q4 2023.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2024.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2024, filed 8 Aug 2024.